Antimuscarinic/Anticholinergic Medications

This tool from the Washington State Hospital Association can assist hospital administration, quality and pharmacy leaders in improving ADE reduction strategies.

Hospitals can use this Tracer Tool to survey and evaluate their processes for adverse drug events regarding anticoagulants, with the goal of providing safe, high-quality patient care.

The American Geriatrics Society (AGS) has released an updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. This article details the methodology and modifications.

This abstract from the American Urogynecologic Society summarizes the lines of treatment for an overactive bladder and cautions the use of anticholinergic medications in frail and cognitively impaired patients.

This checklist from the Minnesota Hospital Association/Partnership for Patients is designed for health care facilities to use to conduct a gap analysis of their storage, preparation and dispensing of anticoagulants.

This checklist from the Anticoagulation Forum supports the Core Elements of Anticoagulation Stewardship Programs and will allow your hospital to assess key elements of successful anticoagulation stewardship efforts and high-quality patient care.

This tool from the Centers for Medicare & Medicaid Services (CMS) is intended to assist facilities in identifying risk factors for adverse drug events and implementing programs to minimize such risks.

Minimum Data Set (MDS) training is available in Section N, Medications – Drug Regimen Review. Scroll down the page to locate the Section N materials.

This mini-toolkit includes resources geared toward improving medication safety.

This short self-study on antimuscarinics provides an overview of the therapeutic uses, acute side effects of commonly used medications (including the mnemonic), contraindications, increased risk of dementia, anticholinergic cognitive burden, and treatment of acute anticholinergic toxicity.

This tool from the Institute for Healthcare Improvement provides instructions for conducting a retrospective review of patient records using triggers to identify possible adverse drug events. Log-in may be required to access information.

La Red de Innovación de la Calidad de TMF, bajo contrato con los Centros de Servicios de Medicare y Medicaid, diseñó este paquete de cambios para proporcionar las estrategias para abordar los eventos adversos de medicamentos.